Development of a high-resolution melting method for screening R188H polymorphism in XRCC2 gene

Iranian Journal of Biotechnology

Volumn 11, Issue 2, 2013, Pages 104-108

  Fayaz, Shima ^a   Fard Esfahani, Pezhman ^a   Khaghani, Shahnaz ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genotyping; HRM; XRCC2

Indexed keywords

GENOMIC DNA;

ARTICLE; CONTROLLED STUDY; GENE; GENETIC SCREENING; GENOTYPE; HETEROZYGOSITY; HIGH RESOLUTION MELTING ANALYSIS; HOMOZYGOSITY; HUMAN; INTERMETHOD COMPARISON; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; XRCC2 GENE;

EID: 84884684670     PISSN: 17283043     EISSN: None     Source Type: Journal    
DOI: 10.5812/ijb.11450     Document Type: Article

References (16)

1. Arizono K, Osada Y, Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol. 2008;38(3):186-91.
2. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1810-8.
3. Wang Y, Yang H, Li H, Li L, Wang H, Liu C, et al. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett. 2009;285(2):134-40.
4. Zhou C, Zhou Y, Li J, Zhang Y, Jiang L, Zeng X, et al. The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Tohoku J Exp Med. 2009;219(1):43-51.
5. Liu N, Lamerdin JE, Tebbs RS, Schild D, Tucker JD, Shen MR, et al. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell. 1998;1(6):783-93.
6. Bastos HN, Antao MR, Silva SN, Azevedo AP, Manita I, Teixeira V, et al. Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk. Thyroid. 2009;19(10):1067-75.
7. Danoy P, Sonoda E, Lathrop M, Takeda S, Matsuda F. A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage. Biochem Biophys Res Commun. 2007;352(3):763-8.
8. Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A. DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer. 2004;112(5):901-4.
9. Jiao L, Hassan MM, Bondy ML, Wolff RA, Evans DB, Abbruzzese JL, et al. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol. 2008;103(2):360-7.
10. Rafii S, O-Regan P, Xinarianos G, Azmy I, Stephenson T, Reed M, et al. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum Mol Genet. 2002;11(12):1433-8.
11. Fard-Esfahani P, Khatami S, Zeinali C, Taghikhani M, Allahyari M. A modified conformation sensitive gel electrophoresis (CSGE) method for rapid and accurate detection of low density lipoprotein (LDL) receptor gene mutations in Familial Hypercholesterolemia. Clin Biochem. 2005;38(6):579-83.
12. Suh Y, Vijg J. SNP discovery in associating genetic variation with human disease phenotypes. Mutat Res. 2005;573(1-2):41-53.
13. Whittall RA, Scartezini M, Li K, Hubbart C, Reiner Z, Abraha A, et al. Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patients. Ann Clin Biochem. 2010;47(Pt 1):44-55.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
15. Chistiakov DA, Voronova NV, Chistiakov PA. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol. 2008;47(5):809-24.
16. Pooley KA, Baynes C, Driver KE, Tyrer J, Azzato EM, Pharoah PD, et al. Common single-nucleotide polymorphisms in DNA doublestrand break repair genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3482-9.